Risks associated with the use of non-steroidal anti-inflammatory drugs during pneumonia - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Revue des Maladies Respiratoires Année : 2018

Risks associated with the use of non-steroidal anti-inflammatory drugs during pneumonia

(1, 2) , , (3, 4) , (5, 6) , (7) , , (5, 6) , (5, 6) , , (1)
1
2
3
4
5
6
7

Résumé

Introduction. -Outpatient treatment of community-acquired pneumonia (CAP) patients with non-steroidal anti-inflammatory drugs (NSAIDs) is frequent, although this is not based on clinical recommendations and there is no scientific evidence supporting better symptom relief in comparison to acetaminophen. State of the art. -Experimental data suggest that NSAIDs alter the intrinsic functions of neutrophils, limit their locoregional recruitment, alter bacterial clearance and delay the resolution of inflammatory processes during acute bacterial pulmonary challenge. In hospitalized children and adults with CAP, observational data suggest a strong and independent association between the outpatient exposure to NSAIDs and the occurrence of pleuropulmonary complications (pleural empyema, excavation, and abscess). In the only study taking into account possible protopathic bias, the association still persists. Other markers of morbidity have been described, including delay in hospital management, prolonged antibiotic therapy, and higher transfer rate to an intensive care unit. Perspectives. -Data describing the role of self-medication and the biological mechanisms involved are needed. Conclusions. -Intake of NSAIDs during outpatient treatment of CAP is probably the second modifiable factor of morbidity after inadequate antibiotic therapy. In light of existing data in children and adults, health authorities should urgently reassess the risk-benefit ratio of NSAIDS in CAR (C) 2018 SPLF. Published by Elsevier Masson SAS. All rights reserved.
Fichier non déposé

Dates et versions

hal-03591333 , version 1 (28-02-2022)

Identifiants

Citer

G. Voiriot, M. Chalumeau, J. Messika, Damien Basille, B. Philippe, et al.. Risks associated with the use of non-steroidal anti-inflammatory drugs during pneumonia. Revue des Maladies Respiratoires, 2018, 35 (4), pp.430-440. ⟨10.1016/j.rmr.2017.12.003⟩. ⟨hal-03591333⟩
11 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook Twitter LinkedIn More